4Imperiale MJ,Pass HI,Sanda MG.Prospects for an SV40 vaccine.Semin Cancer Biol,2001,11(1):81-85.
5Curran D,Sahmoud T,Therasse P,et al.Prognostic factors in patients with pleural mesothelioma:the European Organization for Research and Treatment of Cancer experience.J Clin Oncol,1998,16(1):145-152.
6Armato SG 3rd,Oxnard GR,MacMahon H,et al.Measurement of mesothelioma on thoracic CT scans:a comparison of manual and computer-assisted techniques.Med Phys,2004,31(5):1105-1115.
7Peto J,Hodgson JT,Matthews FE,et al.Continuing increase in mesothelioma mortality in Britain.Lancet,1995,345(8949):535-539.
8Hughes RS.Malignant pleural mesothelioma.Am J Med Sci,2005,329(1):29-44.
9Hodgson JT,Darnton A.The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure.Ann Occup Hyg,2000,44(8):565-601.
10Pass HI,Donington JS,Wu P,et al.Human mesotheliomas contain the simian virus-40 regulatory region and large tumor antigen DNA sequences.J Thorac Cardiovasc Surg,1998,116(5):854-859.
